Literature DB >> 29272405

Selective vulnerability in neuronal populations in nmd/SMARD1 mice.

Eric Villalón1,2, Monir Shababi1,2, Rachel Kline1,2, Zachary C Lorson1,2, Kyra M Florea1,2, Christian L Lorson1,2.   

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an autosomal recessive motor neuron disease causing distal limb muscle atrophy that progresses proximally and is accompanied by diaphragmatic paralysis. Neuromuscular junction (NMJ) alterations have been reported in muscles of SMARD1 model mice, known as nmd mice, with varying degrees of severity, suggesting that different muscles are specifically and selectively resistant or susceptible to denervation. To evaluate the extent of NMJ pathology in a broad range of muscles, a panel of axial and appendicular muscles were isolated and immunostained from nmd mice. These analyses revealed that selective distal appendage muscles were highly vulnerable to denervation. Susceptibility to pathology was not limited to NMJ alterations, but included defects in myelination within those neurons innervating susceptible muscles. Interestingly, end plate fragmentation was present within all muscles independent of the extent of NMJ alterations, suggesting that end plate fragmentation is an early hallmark of SMARD1 pathogenesis. Expressing the full-length IGHMBP2 cDNA using an adeno-associated virus (AAV9) significantly decreased all aspects of muscle and nerve disease pathology. These results shed new light onto the pathogenesis of SMARD1 by identifying specific motor units that are resistant and susceptible to neurodegeneration in an important model of SMARD1.
© The Author(s) 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29272405      PMCID: PMC5886155          DOI: 10.1093/hmg/ddx434

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  61 in total

1.  Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21.

Authors:  K Grohmann; T F Wienker; K Saar; S Rudnik-Schöneborn; G Stoltenburg-Didinger; R Rossi; G Novelli; G Nürnberg; A Pfeufer; B Wirth; A Reis; K Zerres; C Hübner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.

Authors:  S Piepers; W-L van der Pol; F Brugman; J H J Wokke; L H van den Berg
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

3.  Clinical analysis and outcomes of amyotrophic lateral sclerosis with demyelinating polyneuropathy.

Authors:  Nobuhiro Sawa; Hiroshi Kataoka; Kazuma Sugie; Makoto Kawahara; Hirosei Horikawa; Susumu Kusunoki; Satoshi Ueno
Journal:  Amyotroph Lateral Scler       Date:  2012-01

4.  Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival.

Authors:  Terry P Maddatu; Sean M Garvey; David G Schroeder; Wiedong Zhang; Soh-Yule Kim; Anthony I Nicholson; Crystal J Davis; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2005-09-20       Impact factor: 6.150

5.  Conduction through demyelinated plaques in multiple sclerosis: computer simulations of facilitation by short internodes.

Authors:  S G Waxman; M H Brill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

6.  Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.

Authors:  K Grohmann; M Schuelke; A Diers; K Hoffmann; B Lucke; C Adams; E Bertini; H Leonhardt-Horti; F Muntoni; R Ouvrier; A Pfeufer; R Rossi; L Van Maldergem; J M Wilmshurst; T F Wienker; M Sendtner; S Rudnik-Schöneborn; K Zerres; C Hübner
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 7.  Axonal Charcot-Marie-Tooth disease.

Authors:  Michael E Shy; Agnes Patzkó
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

8.  Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.

Authors:  Mariàngels de Planell-Saguer; David G Schroeder; Maria Celina Rodicio; Gregory A Cox; Zissimos Mourelatos
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

9.  Allelic heterogeneity of SMARD1 at the IGHMBP2 locus.

Authors:  I Maystadt; M Zarhrate; P Landrieu; O Boespflug-Tanguy; S Sukno; P Collignon; J Melki; C Verellen-Dumoulin; A Munnich; L Viollet
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

Review 10.  The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.

Authors:  Francesca Porro; Paola Rinchetti; Francesca Magri; Giulietta Riboldi; Monica Nizzardo; Chiara Simone; Chiara Zanetta; Irene Faravelli; Stefania Corti
Journal:  J Neurol Sci       Date:  2014-09-16       Impact factor: 3.181

View more
  8 in total

1.  Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd.

Authors:  Monir Shababi; Caley E Smith; Mona Kacher; Zayd Alrawi; Eric Villalón; Daniel Davis; Elizabeth C Bryda; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2019-10-08       Impact factor: 3.575

2.  Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1.

Authors:  Eric Villalón; Naomi N Lee; Jose Marquez; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2019-06-28       Impact factor: 3.575

3.  The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects.

Authors:  Caley E Smith; Monique A Lorson; Sara M Ricardez Hernandez; Zayd Al Rawi; Jiude Mao; Jose Marquez; Eric Villalón; Amy N Keilholz; Catherine L Smith; Mona O Garro-Kacher; Toni Morcos; Daniel J Davis; Elizabeth C Bryda; Nicole L Nichols; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

Review 4.  Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights.

Authors:  Matteo Saladini; Monica Nizzardo; Alessandra Govoni; Michela Taiana; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  J Cell Mol Med       Date:  2019-12-04       Impact factor: 5.310

5.  Motor function recovery: deciphering a regenerative niche at the neuromuscular synapse.

Authors:  Diego Zelada; Francisca Bermedo-García; Nicolás Collao; Juan P Henríquez
Journal:  Biol Rev Camb Philos Soc       Date:  2020-12-17

Review 6.  Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.

Authors:  Sibylle Jablonka; Luisa Hennlein; Michael Sendtner
Journal:  Neurol Res Pract       Date:  2022-01-04

7.  Functional regeneration of the murine neuromuscular synapse relies on long-lasting morphological adaptations.

Authors:  Francisca Bermedo-García; Diego Zelada; Esperanza Martínez; Lucía Tabares; Juan Pablo Henríquez
Journal:  BMC Biol       Date:  2022-07-08       Impact factor: 7.364

8.  A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1.

Authors:  Monir Shababi; Eric Villalón; Kevin A Kaifer; Vince DeMarco; Christian L Lorson
Journal:  Mol Ther Methods Clin Dev       Date:  2018-08-17       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.